Adding the magnesium to normal anesthetic increases the effect of the same one?

• Conditions: Hallux valgus correction; MedDRA version: 16.1Level: LLTClassification code 10011123Term: Correction Hallux ValgusSystem Organ Class: 100000004865; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2013-004863-30-IT
• Lead Sponsor: niversità Campus Bio-Medico di Roma

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-12-16
• Last Update Posted: 10 February 2014

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patient undergoing Hallux valgus surgery
Age >18 years
ASA I-III
Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Local infection at the site of the block
Allergy to local anestethic

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Evaluation of efficacy of Magnesium as local anesthetic adjuvant;Secondary Objective: not applicable;Primary end point(s): Evaluation of efficacy of Magnesium as local anesthetic adjuvant;Timepoint(s) of evaluation of this end point: Intraoperative: 5 min, 10min, 15 min, 20min. Valuation of block onset<br>Postoperative: 3 h, 6h, 12h, 24h. Valuation of block offset

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): valuation of analgesic needs;Timepoint(s) of evaluation of this end point: Postoperative: 3 h, 6h, 12h, 24h.